The Founder Behind The Platform: How ClinAI Is Reshaping Vendor Selection & Management From Biomedical Engineering To Leading Clinical Operations
Source: ClinAI
Kalyan Obalampalli began his career with a master’s degree in biomedical engineering. Like many in the clinical research field, he entered as a Clinical Research Associate (CRA) and advanced steadily to leading clinical operations across global studies. Over the years, he managed trials in oncology, rare diseases, cardiovascular indications, and more — gaining deep firsthand experience in both vendor selection and vendor management.
At one company, he managed a clinical development portfolio worth over $200 million, keeping his budget within ±5% of projected spend. Yet despite strong operational controls, a persistent issue remained: the inefficiency and fragmentation of the vendor selection process.
“Even when we hit the numbers,” Kalyan recalls, “I always felt like we were leaving money on the table — during both vendor selection and ongoing management.”
A Year That Changed Everything
The realization came into focus during one pivotal year when Kalyan led vendor selection for over $100 million across three trials. He issued RFPs to five vendors per study, resulting in 15 proposals and more than 40 Excel files. Each file was different, each comparison manual, and the analysis — though time-consuming and essential — went largely unrecognized.
“From experience, I knew that selecting the right vendor — not just the cheapest, but the most aligned — is probably the single biggest factor in determining whether a study will complete on time and on budget.”
When he searched for a platform to support that process, nothing fit. There were procurement tools and budget trackers, but no purpose-built solution that could use analytics to drive vendor selection and ongoing management. That’s when Kalyan made a bold decision: he left his job and decided to build the solution himself.
Founding ClinAI: A Platform Designed by an Operator
Kalyan launched ClinAI with a clear vision — to simplify and strengthen vendor selection and management using automation, analytics, and structured collaboration. The platform was built to:
Replace static Excel files with dynamic, comparable data
Bring all RFP components (budget, enrollment, timelines, questions) into a single workflow
Track negotiations and performance over time — from the first RFP to the final invoice
Importantly, ClinAI was built to support not just CRO selection, but all major vendors in clinical development — including central labs, IVRS/IWRS vendors, data management providers, biostatistics vendors, and more.
Early Results That Fueled Momentum
ClinAI’s early growth was powered by forward-thinking users. One of the platform’s first adopters reported a 10% reduction in total cost and an 8-week acceleration in vendor selection timelines.
Shortly after, another sponsor — who had already selected a vendor for $48.5 million for a Phase 3 oncology study — reran their selection process using ClinAI. They ended up selecting a different vendor they believed was better suited, at $40 million — a 17% reduction in cost, just by enabling true one-to-one comparison.
These early wins helped cement the platform’s value and chart the course for the company’s growth
Built for Sponsors — Trusted by Vendors
ClinAI is now used by a growing number of sponsor companies and has facilitated over $1 billion in vendor proposals in just the past 12 months. More than 50 CROs and functional vendors have submitted bids through the platform — including top 10 global vendors and emerging players alike.
Sponsors appreciate the speed, structure, and audit-readiness. But what sets ClinAI apart is that vendors love using it, too — especially smaller vendors.
“We’ve created a level playing field,” Kalyan explains. “Smaller vendors now have a chance to be compared apples to apples with larger players — not penalized for inconsistent formatting or unclear data. It’s fair, efficient, and transparent.”
ClinAI makes it simple for vendors to submit proposals, ask questions, revise budgets, and track changes — all within a single interface. The platform is free for vendors and neutral by design.
“We never recommend vendors. We never push sponsors toward any provider. We just make it easier for them to make the best decision based on real data.”
Beyond Selection: Full Lifecycle Vendor Management
ClinAI has expanded far beyond vendor selection. The platform now supports full lifecycle vendor management, including:
Change order tracking with clear analytics on rate changes, unit increases, and cost shifts
Projections vs. actuals to proactively flag budget drift
Real-time dashboards across studies, programs, and departments
Inspection-ready documentation aligned with evolving ICH E6(R3) guidelines
Whether selecting vendors or managing them post-award, ClinAI provides a single system of record — replacing email chains and spreadsheets with a unified, audit-ready environment.
Powered by Advocacy, Not Advertising
Unlike many startups, ClinAI’s growth hasn’t come from expensive marketing campaigns — it’s come from its users.
“Our customers have been our greatest advocates,” Kalyan says. “They’ve shared their experiences at conferences, written articles about us on Clinical Leader, and promoted the platform —because they believed in what we’re doing.”
From unsolicited case studies to guest panel appearances, the platform’s credibility has grown through word of mouth, grounded in real-world results.
A Simple Premise: Let the Best Partner Win
“If you don’t know how to get somewhere, you use GPS,” Kalyan says. “So when you’re running a clinical trial that could impact lives and cost tens of millions, doesn’t it make sense to use a platform that helps you select — and manage — your vendor partners with confidence?”
That’s the idea behind ClinAI. Built by an operator who lived the problem, it’s now being scaled by the very community it serves — sponsors and vendors alike — to redefine how vendor partnerships are formed and managed in clinical development.
Kalyan Obalampalli (KO)
Kalyan Obalampalli (KO) is a disruptor and technology innovator with over 20 years of experience in leadership positions in Clinical Operations and Outsourcing at major pharma and biotechs. Having served in advisory roles at start-ups in Silicon Valley, Kalyan has a unique perspective on Clinical Development Operations and how technology can help fill gaps.
Kalyan is the Founder and President of Clin.AI, a disruptive start-up that is revolutionizing the way vendor selection and management is conducted in the biotech / pharma space.
.png?raw=true)
.png?raw=true)
.png?raw=true)
